Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Declining invasive pneumococcal disease in the U.S. elderly.

McBean AM, Park YT, Caldwell D, Yu X.

Vaccine. 2005 Dec 1;23(48-49):5641-5. Epub 2005 Jul 27.

PMID:
16111788
2.
3.

Prevenar vaccination: review of the global data, 2006.

Center KJ.

Vaccine. 2007 Apr 20;25(16):3085-9. Epub 2007 Jan 18. Review.

PMID:
17287048
4.

[Two pneumococcal vaccines: the 7-valent conjugate vaccine (Prevenar) for children up to the age of 5 years and the 23-valent polysaccharide vaccine (Pneumo 23) for the elderly and specific groups at risk].

de Greeff SC, Sanders EA, de Melker HE, van der Ende A, Vermeer PE, Schouls LM.

Ned Tijdschr Geneeskd. 2007 Jun 30;151(26):1454-7. Review. Dutch.

PMID:
17633974
5.

Impact of pneumococcal conjugate vaccine on the prevention of invasive pneumococcal diseases.

Bricks LF, Berezin E.

J Pediatr (Rio J). 2006 Jul;82(3 Suppl):S67-74. Epub 2006 May 19. Review.

6.

Pneumococcal vaccine in the elderly: a useful but forgotten vaccine.

Chidiac C, Ader F.

Aging Clin Exp Res. 2009 Jun;21(3):222-8. Review.

PMID:
19571646
7.

Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.

Dagan R.

Clin Microbiol Infect. 2009 Apr;15 Suppl 3:16-20. doi: 10.1111/j.1469-0691.2009.02726.x. Review.

8.

Experience with pneumococcal conjugate vaccine in Norway.

Aaberge IS.

Expert Rev Vaccines. 2009 Feb;8(2):159-65. doi: 10.1586/14760584.8.2.159. Review.

PMID:
19196196
9.

Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe.

Fedson DS, Nicolas-Spony L, Klemets P, van der Linden M, Marques A, Salleras L, Samson SI.

Expert Rev Vaccines. 2011 Aug;10(8):1143-67. doi: 10.1586/erv.11.99. Epub 2011 Aug 3. Review.

PMID:
21810065
10.

The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.

Isaacman DJ, Strutton DR, Kalpas EA, Horowicz-Mehler N, Stern LS, Casciano R, Ciuryla V.

Clin Ther. 2008 Feb;30(2):341-57. doi: 10.1016/j.clinthera.2008.02.003. Review.

PMID:
18343273
11.

Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.

Rose M, Zielen S.

Expert Rev Vaccines. 2009 Oct;8(10):1351-64. doi: 10.1586/erv.09.78. Review.

PMID:
19803758
12.

Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.

Pletz MW, Maus U, Krug N, Welte T, Lode H.

Int J Antimicrob Agents. 2008 Sep;32(3):199-206. doi: 10.1016/j.ijantimicag.2008.01.021. Epub 2008 Apr 18. Review.

PMID:
18378430
13.

Population-based impact of routine infant immunization with pneumococcal conjugate vaccine in the USA.

Grijalva CG, Griffin MR.

Expert Rev Vaccines. 2008 Feb;7(1):83-95. doi: 10.1586/14760584.7.1.83. Review.

PMID:
18251696
14.

[Pneumococcal vaccine].

Ishiwada N.

Nihon Rinsho. 2011 Sep;69(9):1584-8. Review. Japanese.

PMID:
21922757
15.

Rethinking recommendations for use of pneumococcal vaccines in adults.

Whitney CG, Schaffner W, Butler JC.

Clin Infect Dis. 2001 Sep 1;33(5):662-75. Epub 2001 Jul 30. Review.

PMID:
11486289
16.

Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention.

Lynch JP 3rd, Zhanel GG.

Semin Respir Crit Care Med. 2009 Apr;30(2):189-209. doi: 10.1055/s-0029-1202938. Epub 2009 Mar 18. Review.

PMID:
19296419
17.

[Heptavalent-pneumococcal conjugate vaccine (Prevenar). Differences in effectiveness between populations].

Guevara M, Barricarte A, Pérez B, Arriazu M, García Cenoz M, Castilla J.

An Sist Sanit Navar. 2008 May-Aug;31(2):171-92. Review. Spanish.

18.

23-valent pneumococcal polysaccharide vaccine (PPV23) for the prevention of invasive pneumococcal diseases (IPDs) in the elderly: is it really effective?

Cadeddu C, De Waure C, Gualano MR, Di Nardo F, Ricciardi W.

J Prev Med Hyg. 2012 Jun;53(2):101-3. Review.

PMID:
23240169
19.

The heptavalent conjugate pneumococcal vaccine and its implications for managed care--clinical overview and roundtable discussions.

Alexander PG, Chartrand SA, Davies TJ, Gaines BM, Oster G, Shurin P, Tamsky L, Thornton DK, Wittert W.

Manag Care Interface. 2001;Suppl C:10-28; quiz 29-30. Review. No abstract available.

PMID:
11724029
20.

Supplemental Content

Support Center